119 related articles for article (PubMed ID: 29487200)
21. Protein Kinase C Epsilon Cooperates with PTEN Loss for Prostate Tumorigenesis through the CXCL13-CXCR5 Pathway.
Garg R; Blando JM; Perez CJ; Abba MC; Benavides F; Kazanietz MG
Cell Rep; 2017 Apr; 19(2):375-388. PubMed ID: 28402859
[TBL] [Abstract][Full Text] [Related]
22. TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells.
Moreira D; Zhang Q; Hossain DM; Nechaev S; Li H; Kowolik CM; D'Apuzzo M; Forman S; Jones J; Pal SK; Kortylewski M
Oncotarget; 2015 Jul; 6(19):17302-13. PubMed ID: 26046794
[TBL] [Abstract][Full Text] [Related]
23. CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis.
Biswas S; Sengupta S; Roy Chowdhury S; Jana S; Mandal G; Mandal PK; Saha N; Malhotra V; Gupta A; Kuprash DV; Bhattacharyya A
Breast Cancer Res Treat; 2014 Jan; 143(2):265-76. PubMed ID: 24337540
[TBL] [Abstract][Full Text] [Related]
24. RelA driven co-expression of CXCL13 and CXCR5 is governed by a multifaceted transcriptional program regulating breast cancer progression.
Biswas S; Roy Chowdhury S; Mandal G; Purohit S; Gupta A; Bhattacharyya A
Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):502-511. PubMed ID: 30553016
[TBL] [Abstract][Full Text] [Related]
25. Pim Kinases Promote Migration and Metastatic Growth of Prostate Cancer Xenografts.
Santio NM; Eerola SK; Paatero I; Yli-Kauhaluoma J; Anizon F; Moreau P; Tuomela J; Härkönen P; Koskinen PJ
PLoS One; 2015; 10(6):e0130340. PubMed ID: 26075720
[TBL] [Abstract][Full Text] [Related]
26. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
Sun YX; Schneider A; Jung Y; Wang J; Dai J; Wang J; Cook K; Osman NI; Koh-Paige AJ; Shim H; Pienta KJ; Keller ET; McCauley LK; Taichman RS
J Bone Miner Res; 2005 Feb; 20(2):318-29. PubMed ID: 15647826
[TBL] [Abstract][Full Text] [Related]
27. Cyclin A1 and P450 Aromatase Promote Metastatic Homing and Growth of Stem-like Prostate Cancer Cells in the Bone Marrow.
Miftakhova R; Hedblom A; Semenas J; Robinson B; Simoulis A; Malm J; Rizvanov A; Heery DM; Mongan NP; Maitland NJ; Allegrucci C; Persson JL
Cancer Res; 2016 Apr; 76(8):2453-64. PubMed ID: 26921336
[TBL] [Abstract][Full Text] [Related]
28. Expression analysis of putative stem cell markers in human benign and malignant prostate.
Ugolkov AV; Eisengart LJ; Luan C; Yang XJ
Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131
[TBL] [Abstract][Full Text] [Related]
29. The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.
Shiozawa Y; Berry JE; Eber MR; Jung Y; Yumoto K; Cackowski FC; Yoon HJ; Parsana P; Mehra R; Wang J; McGee S; Lee E; Nagrath S; Pienta KJ; Taichman RS
Oncotarget; 2016 Jul; 7(27):41217-41232. PubMed ID: 27172799
[TBL] [Abstract][Full Text] [Related]
30. HOTAIR expands the population of prostatic cancer stem-like cells and causes Docetaxel resistance via activating STAT3 signaling.
Wang N; Jiang Y; Lv S; Wen H; Wu D; Wei Q; Dang Q
Aging (Albany NY); 2020 Jul; 12(13):12771-12782. PubMed ID: 32657763
[TBL] [Abstract][Full Text] [Related]
31. Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCε, Stat3, and Epithelial-to-Mesenchymal Transition Markers.
Hafeez BB; Fischer JW; Singh A; Zhong W; Mustafa A; Meske L; Sheikhani MO; Verma AK
Cancer Prev Res (Phila); 2015 May; 8(5):375-86. PubMed ID: 25627799
[TBL] [Abstract][Full Text] [Related]
32. Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer.
Ronca R; Alessi P; Coltrini D; Di Salle E; Giacomini A; Leali D; Corsini M; Belleri M; Tobia C; Garlanda C; Bonomi E; Tardanico R; Vermi W; Presta M
J Pathol; 2013 Jun; 230(2):228-38. PubMed ID: 23424081
[TBL] [Abstract][Full Text] [Related]
33. Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer.
McGuire JJ; Frieling JS; Lo CH; Li T; Muhammad A; Lawrence HR; Lawrence NJ; Cook LM; Lynch CC
Nat Commun; 2021 Feb; 12(1):723. PubMed ID: 33526787
[TBL] [Abstract][Full Text] [Related]
34. Tumor protein D52 (isoform 3) contributes to prostate cancer cell growth via targeting nuclear factor-κB transactivation in LNCaP cells.
Dasari C; Yaghnam DP; Walther R; Ummanni R
Tumour Biol; 2017 May; 39(5):1010428317698382. PubMed ID: 28466782
[TBL] [Abstract][Full Text] [Related]
35. High C-X-C motif chemokine 5 expression is associated with malignant phenotypes of prostate cancer cells via autocrine and paracrine pathways.
Qi Y; Zhao W; Li M; Shao M; Wang J; Sui H; Yu H; Shao W; Gui S; Li J; Jia X; Jiang D; Li Y; Zhang P; Wang S; Wang W
Int J Oncol; 2018 Jul; 53(1):358-370. PubMed ID: 29749439
[TBL] [Abstract][Full Text] [Related]
36. IQGAP2, A candidate tumour suppressor of prostate tumorigenesis.
Xie Y; Yan J; Cutz JC; Rybak AP; He L; Wei F; Kapoor A; Schmidt VA; Tao L; Tang D
Biochim Biophys Acta; 2012 Jun; 1822(6):875-84. PubMed ID: 22406297
[TBL] [Abstract][Full Text] [Related]
37. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling.
Luo J; Ok Lee S; Liang L; Huang CK; Li L; Wen S; Chang C
Oncogene; 2014 May; 33(21):2768-78. PubMed ID: 23792449
[TBL] [Abstract][Full Text] [Related]
38. CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway.
Zhu Z; Zhang X; Guo H; Fu L; Pan G; Sun Y
Mol Cell Biochem; 2015 Feb; 400(1-2):287-95. PubMed ID: 25476740
[TBL] [Abstract][Full Text] [Related]
39. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A
FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966
[TBL] [Abstract][Full Text] [Related]
40. Organelle-Derived Acetyl-CoA Promotes Prostate Cancer Cell Survival, Migration, and Metastasis via Activation of Calmodulin Kinase II.
Yu G; Cheng CJ; Lin SC; Lee YC; Frigo DE; Yu-Lee LY; Gallick GE; Titus MA; Nutt LK; Lin SH
Cancer Res; 2018 May; 78(10):2490-2502. PubMed ID: 29535221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
